Dormant Company Accounts - DR CLINIVA LIMITED

Dormant Company Accounts - DR CLINIVA LIMITED

DR CLINIVA LIMITED - Company Information

Print Friendly Version

Companies House true 2022-01-01 2022-12-31 false 12354765 uk-bus:Director1 2022-01-01 2022-12-31 12354765 uk-bus:Director2 2022-01-01 2022-12-31 12354765 2022-01-01 2022-12-31 12354765 2022-12-31 12354765 uk-bus:EntityHasNeverTraded 2022-01-01 2022-12-31 12354765 uk-bus:FRS102 2022-01-01 2022-12-31 12354765 uk-bus:FullAccounts 2022-01-01 2022-12-31 12354765 uk-bus:AuditExempt-NoAccountantsReport 2022-01-01 2022-12-31 12354765 2021-12-31 12354765 uk-bus:OrdinaryShareClass1 2022-01-01 2022-12-31 12354765 uk-bus:OrdinaryShareClass2 2022-01-01 2022-12-31 12354765 uk-bus:OrdinaryShareClass3 2022-01-01 2022-12-31 12354765 uk-bus:PreferenceShareClass1 2022-01-01 2022-12-31 12354765 uk-bus:PreferenceShareClass2 2022-01-01 2022-12-31 12354765 uk-bus:PreferenceShareClass3 2022-01-01 2022-12-31 12354765 uk-core:ShareCapitalPreferenceShares 2022-12-31 12354765 uk-core:ShareCapitalPreferenceShares 2021-12-31 iso4217:GBP xbrli:shares

Registered Number 12354765

DR CLINIVA LIMITED

Dormant Accounts

31 December 2022

DR CLINIVA LIMITED Registered Number 12354765

Balance Sheet as at 31 December 2022

2022 2021
£ £
Current assets
Cash at bank and in hand
100
100
Net assets
100
100
Issued share capital
100 Ordinary Shares of £ 1 each 100 100
Total Shareholder funds
100
100

STATEMENTS

  1. For the year ending 31 December 2022 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.
  2. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  4. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 20 May 2023

And signed on their behalf by:
Suzhi Liu, Director